Patent Assignment
Reel/Frame 059240/0463
Change of Name
Recorded: 2022-02-24
Pages: 5
Assignor
LEXICON GENETICS INCORPORATED
Executed: 2007-04-25
Assignee
LEXICON PHARMACEUTICALS, INC.
2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS, TEXAS, 77381
Covered Properties
(9)
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Patent:
6,858,419 →
Application:
10/010,720 →
Novel Human Hydroxylases and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same
Patent:
6,797,510 →
Application:
10/196,927 →
Novel Human Kinases and Polynucleotides Encoding the Same
Novel Human Hydroxylases and Polynucleotides Encoding the Same
Knockout Animals Manifesting Hyperlipidemia
Patent:
7,402,730 →
Application:
11/347,838 →
4-Piperidin-1-Yl-7H-Pyrrolo[2,3-D]Pyrimidine Compounds
Aryl Pyridines and Methods of Their Use
Imidazole-Based Compounds, Compositions Comprising Them and Methods of Their Use
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
Release of Security Interest
Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
Security Interest
Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →